A simple prognostic model involving prostate-specific antigen, alkaline phosphatase and albumin for predicting the time required to progress to castration-resistant prostate cancer in patients who received androgen deprivation therapy

Wei Lv,Hongxiang Shang,Xinqi Pei,Yule Chen,Hongjun Xie,Dalin He,Xinyang Wang,Lei Li

A simple prognostic model involving prostate-specific antigen, alkaline phosphatase and albumin for predicting the time required to progress to castration-resistant prostate cancer in patients who received androgen deprivation therapy

2017

Wei Lv
Hongxiang Shang
Xinqi Pei
Yule Chen
Hongjun Xie
Dalin He
Xinyang Wang
Lei Li

Purpose To distinguish potential biomarkers and build a useful model to predict the time required to progress to castration-resistant prostate cancer (CRPC) in patients with prostate cancer who have been treated with androgen deprivation therapy (ADT).

Keywords:

Alkaline phosphatase
Prostate-specific antigen
Prostate cancer
Androgen deprivation therapy
Biomarker (medicine)
Endocrinology
Albumin
PCA3
Medicine
Internal medicine
Diabetes mellitus
Nephrology
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations